• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Altimmune, Inc. - Common Stock (NQ:ALT)

    3.560 -0.050 (-1.39%)
    Streaming Delayed Price Updated: 12:32 PM EST, Jan 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,718,526
    Open 3.620
    Bid (Size) 3.550 (2,500)
    Ask (Size) 3.560 (900)
    Prev. Close 3.610
    Today's Range 3.520 - 3.660
    52wk Range 2.900 - 7.830
    Shares Outstanding 95,598,665
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Altimmune Stock Soars Over 10% Premarket On Positive Mid-Stage Data For Liver Disease Treatment Drug ↗
    New 48-week data showed its dual-action drug outperformed placebo across key non-invasive liver tests. 
    Via Stocktwits
    News headline image
    Altimmune Stock Attracts Strong Retail Buzz As Investors Count Down To 48-Week Data For Its Fatty Liver Treatment ↗
    Retail traders focused on AI-driven biopsy findings and clearer dose-response exuded increased confidence in pemvidutide’s potential. 
    Via Stocktwits

    Performance

    YTD
    N/A
    N/A
    1 Month
    -25.2%
    -25.2%
    3 Month
    -9.4%
    -9.4%
    6 Month
    -25.2%
    -25.2%
    1 Year
    -49.9%
    -49.9%

    More News

    Read More
    News headline image
    Earnings Scheduled For November 6, 2025 ↗
    Via Benzinga
    News headline image
    Important Notice to Long-Term Shareholders of Altimmune, Inc. (NASDAQ: ALT); Five Below, Inc. (NASDAQ: FIVE); Flywire Corporation (NASDAQ: FLYW); and Hertz Global Holdings, Inc. (NASDAQ: HTZ): Grabar Law Office is Investigating Claims on Your Behalf
    From Grabar Law Office
    Via GlobeNewswire
    News headline image
    Altimmune Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) ↗
    Via Benzinga
    News headline image
    ALTIMMUNE ALERT: Bragar Eagel & Squire, P.C. is Investigating Altimmune, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
    From Faruqi & Faruqi, LLP
    Via Business Wire
    News headline image
    ALTIMMUNE FINAL DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges Investors to Contact the Firm Regarding the October 6th Deadline
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Levi & Korsinsky Reminds Altimmune Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 6, 2025 - ALT
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    Levi & Korsinsky Reminds Altimmune Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 6, 2025 - ALT
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    ALT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    ALTIMMUNE CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Investors of October 6th Deadline and Urges Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Altimmune, Inc. Class Action: Levi & Korsinsky Reminds Altimmune Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 6, 2025 - ALT
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    Altimmune, Inc. Class Action: Levi & Korsinsky Reminds Altimmune Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 6, 2025 - ALT
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    Contact Levi & Korsinsky by October 6, 2025 Deadline to Join Class Action Against Altimmune, Inc. (ALT)
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    Contact Levi & Korsinsky by October 6, 2025 Deadline to Join Class Action Against Altimmune, Inc. (ALT)
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    ALT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 6 Deadline in Securities Class Action - ALT
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Altimmune, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ALT
    From DJS Law Group
    Via Business Wire
    News headline image
    INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    DEADLINE APPROACHING: Berger Montague Advises Altimmune, Inc. (NASDAQ: ALT) Investors to Inquire About a Securities Fraud Class Action by October 6, 2025
    From Berger Montague
    Via GlobeNewswire
    News headline image
    Altimmune, Inc. Class Action: Levi & Korsinsky Reminds Altimmune Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 6, 2025 - ALT
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    Altimmune, Inc. Class Action: Levi & Korsinsky Reminds Altimmune Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 6, 2025 - ALT
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    ALTIMMUNE (ALT) DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Investors to Contact the Firm Before the October 6th Deadline in the Altimmune Class Action Lawsuit
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    10 Health Care Stocks With Whale Alerts In Today's Session ↗
    Via Benzinga
    News headline image
    Investors Who Lost Money on Altimmune, Inc. (ALT) Should Contact Levi & Korsinsky About Pending Class Action - ALT
    Via NewMediaWire
    Topics Fraud Lawsuit

    Frequently Asked Questions

    Is Altimmune, Inc. - Common Stock publicly traded?
    Yes, Altimmune, Inc. - Common Stock is publicly traded.
    What exchange does Altimmune, Inc. - Common Stock trade on?
    Altimmune, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Altimmune, Inc. - Common Stock?
    The ticker symbol for Altimmune, Inc. - Common Stock is ALT on the Nasdaq Stock Market
    What is the current price of Altimmune, Inc. - Common Stock?
    The current price of Altimmune, Inc. - Common Stock is 3.560
    When was Altimmune, Inc. - Common Stock last traded?
    The last trade of Altimmune, Inc. - Common Stock was at 01/02/26 12:32 PM ET
    What is the market capitalization of Altimmune, Inc. - Common Stock?
    The market capitalization of Altimmune, Inc. - Common Stock is 340.33M
    How many shares of Altimmune, Inc. - Common Stock are outstanding?
    Altimmune, Inc. - Common Stock has 340M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.